Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Veraxa Biotech AG - Ordinary Shares
(NQ:
VRXA
)
2.300
-0.610 (-20.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
828,314
Open
2.770
Bid (Size)
2.270 (1,100)
Ask (Size)
2.320 (400)
Prev. Close
2.910
Today's Range
2.050 - 2.800
52wk Range
2.050 - 27.36
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline
Today 11:20 EDT
Via
Investor Brand Network
BillionDollarBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline
Today 9:05 EDT
Via
Investor Brand Network
Performance
YTD
-90.7%
-90.7%
1 Month
-90.7%
-90.7%
3 Month
-90.7%
-90.7%
6 Month
-90.7%
-90.7%
1 Year
-90.7%
-90.7%
More News
Read More
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
Today 7:00 EDT
From
VERAXA Biotech GmbH
Via
GlobeNewswire
BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
June 22, 2026
Via
Investor Brand Network
VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
June 11, 2026
Via
Investor Brand Network
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
June 22, 2026
Via
Investor Brand Network
BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform
June 18, 2026
Via
Investor Brand Network
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
June 18, 2026
From
VERAXA Biotech GmbH
Via
GlobeNewswire
InvestorNewsBreaks – Why VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
June 16, 2026
Via
Investor Brand Network
BioMedNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Completes Business Combination and Begins Trading on Nasdaq
June 11, 2026
Via
Investor Brand Network
Frequently Asked Questions
Is Veraxa Biotech AG - Ordinary Shares publicly traded?
Yes, Veraxa Biotech AG - Ordinary Shares is publicly traded.
What exchange does Veraxa Biotech AG - Ordinary Shares trade on?
Veraxa Biotech AG - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Veraxa Biotech AG - Ordinary Shares?
The ticker symbol for Veraxa Biotech AG - Ordinary Shares is VRXA on the Nasdaq Stock Market
What is the current price of Veraxa Biotech AG - Ordinary Shares?
The current price of Veraxa Biotech AG - Ordinary Shares is 2.300
When was Veraxa Biotech AG - Ordinary Shares last traded?
The last trade of Veraxa Biotech AG - Ordinary Shares was at 06/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.